Spirostanol saponins, 1−6 and 18−19 (normal-type F ring), isolated from Solanum torvum and S. macaonense showed anti-metastatic and anti-inflammatory effects, especially 2 and 18 could be chosen as the promising candidates against inflammation-associated tumors.
The EtOAc-soluble fractions of Solanum torvum and S. macaonense prepared from their MeOH extracts via partitioning between ethyl acetate (EtOAc) and H 2 O (1:1, v/v) were active toward human MDA-MB-231 breast cancer cells (IC 50 < 50 μg/mL), and the latter one could be cytotoxic against HSC-3 oral and A549 lung cancer cells with the cell viabilities of 43.6 and 59.2 % at the concentration of 20 μg/mL (Table 1 ). The major components of above-mentioned two Solanum plants were saponins [1, 2] , which have been reported as the cytotoxic agents [3] . In this research, compounds 1−7, 10, and macaosides I−J, M−N, P−R (8−9, 11−15) from S. macaonens [2] , and compounds 18−19, torvosides J−L, Q (20, 17, 16, 21), paniculonin B (22), (22R,23S,25R)-3β,6α,23-trihydroxy-5α-spirostane 6-O-β-Dxylopyranosyl-(1→3)-O-β-D-quinovopyranoside (23), solanolactoside A (24), torvpregnanosides A (25) from S. torvum [1] , were isolated in sufficient quantity and assayed for cytotoxicity.
Compounds 1−7, 18−19, and 21−22 (normal-type F ring) as well as 16−17, 20, and 23 (iso-type F ring) are spirostanol derivatives. Compounds 8−15 and 24−25 are furostanol and pregnane-type steroidal glycosides, respectively. As Table 2 shown, spirostanols 1, 2, 5, and furostanol 10 have moderate cytotoxicities toward cancer cell lines, while others were inactive. These results indicated the structure-activity relationship of the aglycone part of Solanum saponins was suggested spirostane > furostane > pregnane types and the E ring of the spirostane skeleton should be essential for contribution to cytotoxicity [4] . To examine the anti-metastatic effect of saponins 1−25 in vitro, wound healing assays on A549 for 24 h were conducted to monitor cell motility. As shown in Figure 2 for 1−15, spirostanols 1−5 and 7 showed inhibition against cancer cell migrations at the concentration of 50 M, notably 1 and 2 that could remarkably suppressed wound migration by 71.7% and 73.0% in comparison with control cells, respectively. However, 1−5 and 7 did not have effect at the lower concentration of 25 M (Figure 2 ). In addition, among 16−25 from S. torvum, 18 and 19 could lead to 26.0% and 60.3% healing at 20 g/mL, respectively (Figure 3 ).
Compounds 1−6 and 18−19 which showed antineutrophilic inflammatory effects [1, 2] , were not able to inhibit immediately allergic degranulation in rat basophilic leukemia RBL-2H3 cells (data not shown), but 2, 4, 5, 6, and 18 could be significantly against interleukin-4 (IL-4) release that is a late-phase response of allergic inflammation reaction (Figure 4) . In our studies, saponins 2 and 18 isolated from above-mentioned two Solanum species have both anti-metastatic and anti-inflammatory effects in accordance with anti-inflammatory phytochemicals are potential candidates against tumor metastasis [5] . Spirostanols 2 and 18 could be as the promising lead compounds against inflammation-associated tumors. 
Experimental
General: Compounds 1−15 and 16−25 were isolated from S. macaonens and S. torvum, respectively [1, 2] .
Cytotoxicity: Compounds were tested against human lung (A549), breast (MCF-7), ovarian (SKOV3), colon (HCT116), prostate (DU145), and oral (Ca922) cancer cell lines using an MTT assay. The absorbance was measured at 550 nm using a microplate reader.
Cell migration assay:
The migration assay was carried out in a costar transwell with cell permeable membrane. The A549 cells (2 × 10 5 cells/well) were seeded to the upper wells with and without test compounds for 4 h. FBS medium (20%) was added to the lower wells as a chemoattractant. After 24 h, the membrane was fixed for 10 min with 4% paraformaldehyde and stained for 10 min with crystal violet. Wound migration was monitored using a phasecontrast microscope (×100) and estimated by counting the stained cells in five random fields.
β-Hexosaminidase degranulation assay:
Analysis on βhexosaminidase activity released from RBL-2H3 cells was carried out according to our established protocols [2] .
Enzyme-linked immunoabsorbent assay (ELISA) for measuring interleukin-4 (IL-4) release:
The IL-4 release was measured by an ELISA, which was devised by coating 96-well plates of monoclonal antibody with specificity for IL-4. An IL-4 ELISA was performed according to the manufacturer's instructions (DueSet ELISA Rat IL-4 Catalog Number DY504). RBL-2H3 cells, either with or without treated compounds, were seeded into 96-well plates (10 5 cells/well) and incubated with 0.5 nM IgE-DNP followed by crosslinking of DNP-BSA for 6 h. Supernatants were transferred into 96-well plates according to the manufacturer's instructions.
